Plasma fatty acid esters of hydroxy fatty acids and surrogate fatty acid esters of hydroxy fatty acids hydrolysis activity in children with or without obesity and in adults with or without coronary artery disease.

cardiovascular disease obesity observational study type 2 diabetes

Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
29 May 2024
Historique:
revised: 09 05 2024
received: 02 03 2024
accepted: 10 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 30 5 2024
Statut: aheadofprint

Résumé

Fatty acid esters of hydroxy fatty acids (FAHFA) are a class of bioactive lipids with anti-inflammatory, antidiabetic and cardioprotective properties. FAHFA hydrolysis into its fatty acid (FA) and hydroxy fatty acid (HFA) constituents can affect the bioavailability of FAHFA and its subsequent biological effects. We aimed to investigate FAHFA levels and FAHFA hydrolysis activity in children with or without obesity, and in adults with or without coronary artery disease (CAD). Our study cohort included 20 children without obesity, 40 children with obesity, 10 adults without CAD and 28 adults with CAD. We quantitated plasma levels of four families of FAHFA [palmitic acid hydroxy stearic acid (PAHSA), palmitoleic acid hydroxy stearic acid (POHSA), oleic acid hydroxy stearic acid (OAHSA), stearic acid hydroxy stearic acid] and their corresponding FA and HFA constituents using liquid chromatography-tandem mass spectrometry analysis. Surrogate FAHFA hydrolysis activity was estimated as the FA/FAHFA or HFA/FAHFA ratio. Children with obesity had lower plasma PAHSA (p = .001), OAHSA (p = .006) and total FAHFA (p = .011) levels, and higher surrogate FAHFA hydrolysis activity represented by PA/PAHSA (p = .040) and HSA/OAHSA (p = .025) compared with children without obesity. Adults with CAD and a history of myocardial infarction (MI) had lower POHSA levels (p = .026) and higher PA/PAHSA (p = .041), POA/POHSA (p = .003) and HSA/POHSA (p = .038) compared with those without MI. Altered FAHFA metabolism is associated with obesity and MI, and inhibition of FAHFA hydrolysis should be studied further as a possible therapeutic strategy in obesity and MI.

Identifiants

pubmed: 38812281
doi: 10.1111/dom.15686
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Khoo Teck Puat-National University Children's Medical Institute research grant

Informations de copyright

© 2024 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Références

Barnes AS. The epidemic of obesity and diabetes: trends and treatments. Tex Heart Inst J. 2011;38(2):142‐144.
Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723‐1735.
Shah NS, Lloyd‐Jones DM, O'Flaherty M, et al. Trends in cardiometabolic mortality in the United States, 1999‐2017. Jama. 2019;322(8):780‐782.
Yore MM, Syed I, Moraes‐Vieira PM, et al. Discovery of a class of endogenous mammalian lipids with anti‐diabetic and anti‐inflammatory effects. Cell. 2014;159(2):318‐332.
Wang Y‐M, Mi S‐L, Jin H, et al. 9‐PAHSA improves cardiovascular complications by promoting autophagic flux and reducing myocardial hypertrophy in Db/Db mice. Front Pharmacol. 2021;12:754387.
Aryal P, Syed I, Lee J, et al. Distinct biological activities of isomers from several families of branched fatty acid esters of hydroxy fatty acids (FAHFAs). J Lipid Res. 2021;62:100108.
Kuda O, Brezinova M, Rombaldova M, et al. Docosahexaenoic acid–derived fatty acid esters of hydroxy fatty acids (FAHFAs) with anti‐inflammatory properties. Diabetes. 2016;65(9):2580‐2590.
Kolar MJ, Konduri S, Chang T, et al. Linoleic acid esters of hydroxy linoleic acids are anti‐inflammatory lipids found in plants and mammals. J Biol Chem. 2019;294(27):10698‐10707.
Syed I, Lee J, Moraes‐Vieira PM, et al. Palmitic acid Hydroxystearic acids activate GPR40, which is involved in their beneficial effects on glucose homeostasis. Cell Metab. 2018;27(2):419‐427.
Kellerer T, Kleigrewe K, Brandl B, Hofmann T, Hauner H, Skurk T. Fatty acid esters of hydroxy fatty acids (FAHFAs) are associated with diet, BMI, and age. Front Nutr. 2021;8:691401.
Dongoran RA, Lin T‐J, Byekyet A, Tang S‐C, Yang J‐H, Liu C‐H. Determination of major endogenous FAHFAs in healthy human circulation: the correlations with several circulating cardiovascular‐related biomarkers and anti‐inflammatory effects on RAW 264.7 cells. Biomolecules. 2020;10(12):1689.
Brezinova M, Kuda O, Hansikova J, et al. Levels of palmitic acid ester of hydroxystearic acid (PAHSA) are reduced in the breast milk of obese mothers. Biochimica et Biophysica acta (BBA)—molecular and cell biology of Lipids. 2018;1863(2):126‐131.
Zhu Q‐F, Yan J‐W, Gao Y, Zhang J‐W, Yuan B‐F, Feng Y‐Q. Highly sensitive determination of fatty acid esters of hydroxyl fatty acids by liquid chromatography‐mass spectrometry. J Chromatogr B. 2017;1061‐1062:34‐40.
Hu C, Wang M, Duan Q, Han X. Sensitive analysis of fatty acid esters of hydroxy fatty acids in biological lipid extracts by shotgun lipidomics after one‐step derivatization. Anal Chim Acta. 2020;1105:105‐111.
Parsons WH, Kolar MJ, Kamat SS, et al. AIG1 and ADTRP are atypical integral membrane hydrolases that degrade bioactive FAHFAs. Nat Chem Biol. 2016;12(5):367‐372.
Erikci Ertunc M, Kok BP, Parsons WH, et al. AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in mice. J Biol Chem. 2020;295(18):5891‐5905.
Kolar MJ, Kamat SS, Parsons WH, et al. Branched fatty acid esters of hydroxy fatty acids are preferred substrates of the MODY8 protein carboxyl Ester lipase. Biochemistry. 2016;55(33):4636‐4641.
Brejchova K, Radner FPW, Balas L, et al. Distinct roles of adipose triglyceride lipase and hormone‐sensitive lipase in the catabolism of triacylglycerol estolides. Proc Natl Acad Sci. 2021;118(2):e2020999118.
Ooi DSQ, Ong SG, Lee OMH, et al. Prevalence and predictors of metabolically healthy obesity in severely obese Asian children. Pediatr Res. 2022;92(5):1374‐1380.
Loh WJ, Chang X, Aw TC, et al. Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi‐ethnic Asian population. Atherosclerosis. 2022;349:160‐165.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618‐e651.
Health Promotion Board (HPB) S. Child Health Booklet. Health Promotion Board (HPB), Singapore. https://www.healthhub.sg/sites/assets/Assets/Programs/parenting_portal/pdf/ECN_CHB_A5_72pp_Web.pdf.
Zhang T, Chen S, Syed I, et al. A LC‐MS–based workflow for measurement of branched fatty acid esters of hydroxy fatty acids. Nat Protoc. 2016;11(4):747‐763.
Kolar MJ, Nelson AT, Chang T, et al. Faster protocol for endogenous fatty acid esters of hydroxy fatty acid (FAHFA) measurements. Anal Chem. 2018;90(8):5358‐5365.
Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911‐917.
Ulvik A, Theofylaktopoulou D, Midttun Ø, Nygård O, Eussen SJPM, Ueland PM. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B‐6 status. Am J Clin Nutr. 2013;98(4):934‐940.
Wancewicz B, Zhu Y, Fenske RJ, et al. Metformin monotherapy alters the human plasma lipidome independent of clinical markers of glycemic control and cardiovascular disease risk in a type 2 diabetes clinical cohort. Journal of Pharmacology and Experimental Therapeutics. 2023;386(2):169‐180.
Xuan C, Tian Q‐W, Li H, Guo J‐J, He G‐W, Lun L‐M. Serum fatty acids profile and association with early‐onset coronary artery disease. Therapeutic Advances in Chronic Disease. 2021;12:20406223211033102.
Ma P, Han L, Lv Z, et al. In‐hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome. BMC Cardiovasc Disord. 2016;16(1):29.
Yagi S, Aihara K‐i, Fukuda D, et al. Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome. Nutr J. 2015;14(1):111.
Lee J, Moraes‐Vieira PM, Castoldi A, et al. Branched fatty acid esters of hydroxy fatty acids (FAHFAs) protect against colitis by regulating gut innate and adaptive immune responses. J Biol Chem. 2016;291(42):22207‐22217.
Kee Z, Ong SM, Heng C‐K, Ooi DSQ. Androgen‐dependent tissue factor pathway inhibitor regulating protein: a review of its peripheral actions and association with cardiometabolic diseases. J Mol Med. 2022;100(2):185‐196.
Wang F, Xu C‐Q, He Q, et al. Genome‐wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet. 2011;43(4):345‐349.
Guo C‐Y, Gu Y, Li L, et al. Association of SNP Rs6903956 on chromosome 6p24.1 with angiographical characteristics of coronary atherosclerosis in a Chinese population. PLoS One. 2012;7(8):e43732.
Tayebi N, Ke T, Foo JN, Friedlander Y, Liu J, Heng C‐K. Association of single nucleotide polymorphism rs6903956 on chromosome 6p24.1 with coronary artery disease and lipid levels in different ethnic groups of the Singaporean population. Clin Biochem. 2013;46(9):755‐759.
Ooi DSQ, Ong SM, Eng MH, et al. Detection of ADTRP in circulation and its role as a novel biomarker for coronary artery disease. PLoS One. 2020;15(8):e0237074.
Ræder H, Johansson S, Holm PI, et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet. 2006;38(1):54‐62.
Johansson BB, Torsvik J, Bjørkhaug L, et al. Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl Ester lipase gene‐maturity onset diabetes of the young (CEL‐MODY): a protein misfolding disease. J Biol Chem. 2011;286(40):34593‐34605.
Kraemer FB, Shen W‐J. Hormone‐sensitive lipase. J Lipid Res. 2002;43(10):1585‐1594.
Large V, Reynisdottir S, Langin D, et al. Decreased expression and function of adipocyte hormone‐sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res. 1999;40(11):2059‐2065.
Jocken JWE, Langin D, Smit E, et al. Adipose triglyceride lipase and hormone‐sensitive lipase protein expression is decreased in the obese insulin‐resistant state. J Clin Endocrinol Metabol. 2007;92(6):2292‐2299.
Watt MJ, Carey AL, Wolsk‐Petersen E, Kraemer FB, Pedersen BK, Febbraio MA. Hormone‐sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL‐6 infusion. Diabetologia. 2005;48(1):105‐112.
Raatz SK, Bibus D, Thomas W, Kris‐Etherton P. Total fat intake modifies plasma fatty acid composition in humans. J Nutr. 2001;131(2):231‐234.
Kris‐Etherton PM, Krummel D, Russell ME, et al. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc. 1988;88(11):1373‐1400.
Wilson R, Lyall K, Smyth L, Fernie CE, Riemersma RA. Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of ‘oxidative stress’ in vivo. Free Radical Biology and Medicine. 2002;32(2):162‐168.
López‐Lara IM, Soto MJ. Fatty acid synthesis and regulation. In: Geiger O, ed. Biogenesis of Fatty Acids, Lipids and Membranes. Springer International Publishing; 2018:1‐17.
Patel R, Santoro A, Hofer P, et al. ATGL is a biosynthetic enzyme for fatty acid esters of hydroxy fatty acids. Nature. 2022;606(7916):968‐975.
Tan D, Ertunc ME, Konduri S, et al. Discovery of FAHFA‐containing triacylglycerols and their metabolic regulation. J Am Chem Soc. 2019;141(22):8798‐8806.

Auteurs

Sze Min Ong (SM)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.

Daniel Zhi Wei Ng (DZW)

Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.

Thaddeus En Zhe Chee (TEZ)

Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.

Andrew Anjian Sng (AA)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.

Chew Kiat Heng (CK)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.

Yung Seng Lee (YS)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.

Eric Chun Yong Chan (ECY)

Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.

Delicia Shu Qin Ooi (DSQ)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.

Classifications MeSH